212 related articles for article (PubMed ID: 30991396)
1. Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.
Tsuchie H; Emori M; Nagasawa H; Miyakoshi N; Murahashi Y; Shimizu J; Mizushima E; Yamashita T; Shimada Y
Med Princ Pract; 2019; 28(5):425-431. PubMed ID: 30991396
[TBL] [Abstract][Full Text] [Related]
2. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences.
Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A
BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
4. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma in the first decade of life.
Nagarajan R; Weigel BJ; Thompson RC; Perentesis JP
Med Pediatr Oncol; 2003 Nov; 41(5):480-3. PubMed ID: 14515397
[No Abstract] [Full Text] [Related]
6. Primary osteogenic sarcoma with pulmonary metastasis: clinical results and prognostic factors in 91 patients.
Wu PK; Chen WM; Chen CF; Lee OK; Haung CK; Chen TH
Jpn J Clin Oncol; 2009 Aug; 39(8):514-22. PubMed ID: 19525290
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in elderly osteosarcoma patients: a multi-institutional retrospective study of 86 cases.
Iwata S; Ishii T; Kawai A; Hiruma T; Yonemoto T; Kamoda H; Asano N; Takeyama M
Ann Surg Oncol; 2014 Jan; 21(1):263-8. PubMed ID: 23975321
[TBL] [Abstract][Full Text] [Related]
8. Primary bone sarcomas in patients over 40 years of age: A retrospective study using data from the Bone Tumor Registry of Japan.
Nagano A; Ishimaru D; Nishimoto Y; Akiyama H; Kawai A
J Orthop Sci; 2017 Jul; 22(4):749-754. PubMed ID: 28412026
[TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma treatment: state of the art.
Ta HT; Dass CR; Choong PF; Dunstan DE
Cancer Metastasis Rev; 2009 Jun; 28(1-2):247-63. PubMed ID: 19214708
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in High-Grade Localized Osteosarcoma of the Extremities: The Tunisian Experience.
Letaief F; Khrouf S; Yahiaoui Y; Hamdi A; Gabsi A; Ayadi M; Mezlini A
J Orthop Surg (Hong Kong); 2020; 28(3):2309499020974501. PubMed ID: 33283661
[TBL] [Abstract][Full Text] [Related]
11. Statistics of bone sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jan; 22(1):133-143. PubMed ID: 27847134
[TBL] [Abstract][Full Text] [Related]
12. Primary osteosarcoma in patients older than 40 years of age.
Jeon DG; Lee SY; Cho WH; Song WS; Park JH
J Korean Med Sci; 2006 Aug; 21(4):715-8. PubMed ID: 16891818
[TBL] [Abstract][Full Text] [Related]
13. Primary high-grade osteosarcoma: comparison between preadolescent and older patients.
Bacci G; Longhi A; Bertoni F; Bacchini P; Ruggeri P; Versari M; Picci P
J Pediatr Hematol Oncol; 2005 Mar; 27(3):129-34. PubMed ID: 15750443
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of surgical treatment for excessive elderly patients with soft tissue sarcoma.
Tsuchie H; Emori M; Nagasawa H; Miyakoshi N; Murahashi Y; Mizushima E; Yamashita T; Shimada Y
Int J Clin Oncol; 2018 Aug; 23(4):775-782. PubMed ID: 29488145
[TBL] [Abstract][Full Text] [Related]
15. Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.
Kumar R; Kumar M; Malhotra K; Patel S
Curr Oncol Rep; 2018 Feb; 20(2):13. PubMed ID: 29492676
[TBL] [Abstract][Full Text] [Related]
16. Non-metastatic osteosarcoma of the extremities in children aged 5 years or younger.
Abate ME; Longhi A; Galletti S; Ferrari S; Bacci G
Pediatr Blood Cancer; 2010 Oct; 55(4):652-4. PubMed ID: 20806363
[TBL] [Abstract][Full Text] [Related]
17. Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group.
Bielack SS; Kempf-Bielack B; Heise U; Schwenzer D; Winkler K
J Clin Oncol; 1999 Apr; 17(4):1164. PubMed ID: 10561175
[TBL] [Abstract][Full Text] [Related]
18. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma.
Kim MS; Lee SY; Lee TR; Cho WH; Song WS; Koh JS; Lee JA; Yoo JY; Jeon DG
Ann Oncol; 2009 May; 20(5):955-60. PubMed ID: 19153123
[TBL] [Abstract][Full Text] [Related]
19. The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.
Wang TI; Wu PK; Chen CF; Chen WM; Yen CC; Hung GY; Liu CL; Chen TH
Jpn J Clin Oncol; 2011 Nov; 41(11):1244-50. PubMed ID: 21994209
[TBL] [Abstract][Full Text] [Related]
20. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
